Katrine Bosley - Net Worth and Insider Trading
Katrine Bosley Net Worth
The estimated net worth of Katrine Bosley is at least $5 Million dollars as of 2024-09-20. Katrine Bosley is the President and CEO of Editas Medicine Inc and owns about 1,204,966 shares of Editas Medicine Inc (EDIT) stock worth over $5 Million. Details can be seen in Katrine Bosley's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Katrine Bosley has not made any transactions after 2019-01-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Katrine Bosley
Katrine Bosley Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Katrine Bosley owns 3 companies in total, including Genocea Biosciences Inc (GNCAQ) , Editas Medicine Inc (EDIT) , and Genocea Biosciences Inc (GGNNQ) .
Click here to see the complete history of Katrine Bosley’s form 4 insider trades.
Insider Ownership Summary of Katrine Bosley
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
GNCAQ | Genocea Biosciences Inc | 2015-02-26 | director |
EDIT | Editas Medicine Inc | 2019-01-08 | director & 10 percent owner & President and CEO |
GGNNQ | Genocea Biosciences Inc | 2015-02-26 | director |
Katrine Bosley Latest Holdings Summary
Katrine Bosley currently owns a total of 1 stock. Katrine Bosley owns 1,204,966 shares of Editas Medicine Inc (EDIT) as of January 8, 2019, with a value of $5 Million.
Latest Holdings of Katrine Bosley
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
EDIT | Editas Medicine Inc | 2019-01-08 | 1,204,966 | 3.75 | 4,518,623 |
Holding Weightings of Katrine Bosley
Katrine Bosley Form 4 Trading Tracker
According to the SEC Form 4 filings, Katrine Bosley has made a total of 0 transactions in Editas Medicine Inc (EDIT) over the past 5 years. The most-recent trade in Editas Medicine Inc is the sale of 12,000 shares on January 8, 2019, which brought Katrine Bosley around $303,240.
Insider Trading History of Katrine Bosley
- 1
Katrine Bosley Trading Performance
Katrine Bosley Ownership Network
Katrine Bosley Owned Company Details
What does Genocea Biosciences Inc do?
Who are the key executives at Genocea Biosciences Inc?
Katrine Bosley is the director of Genocea Biosciences Inc. Other key executives at Genocea Biosciences Inc include CHIEF LEGAL & COMPLIANCE OFF Jacquelyn L Sumer , director & President and CEO William D Clark , and CHIEF FINANCIAL OFFICER Diantha Duvall .
Genocea Biosciences Inc (GNCAQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GNCAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GNCAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Genocea Biosciences Inc (GNCAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Genocea Biosciences Inc Insider Transactions
Katrine Bosley Mailing Address
Above is the net worth, insider trading, and ownership report for Katrine Bosley. You might contact Katrine Bosley via mailing address: C/o Editas Medicine, 11 Hurley Street, Cambridge Ma 02141.